Empresa CytRx Corporation Nasdaq
Acciones
US2328286081
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10/01/22 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01/10/07 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Felix Kratz
PRN | Corporate Officer/Principal | - | 17/03/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29/07/21 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27/07/22 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12/07/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 495 092 | 492 306 ( 99,44 %) | 0 | 99,44 % |
Información de la empresa
LadRx Corp.
11726 San Vicente Boulevard Suite 650
90049, Los Angeles
+310 826 5648
http://www.ladrxcorp.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,12 % | 49,46 mil M | |
+1,55 % | 42,58 mil M | |
+49,11 % | 42,49 mil M | |
-4,22 % | 29,09 mil M | |
+11,48 % | 26,61 mil M | |
-22,77 % | 18,64 mil M | |
+8,01 % | 13,16 mil M | |
+29,33 % | 12,55 mil M | |
+24,34 % | 12,1 mil M |